These results were obtained by in vitro and in vivo studies and were confirmed by analyzing monocytes/macrophages from AD patients; as a matter of fact, the monocytic CB2 and FAAH levels significantly correlated with clinical scores [61]. This evidence concerns the gene FAAH and Alzheimer disease.